Evidence map›Paper›PMID 34981683›Full record

ArticleJournal of Korean medical science2022

Analysis of Critical COVID-19 Cases Among Children in Korea.

Hyunju Lee, Sujin Choi, Ji Young Park, Dae Sun Jo, Ui Yoon Choi, Heayon Lee, Yun Tae Jung, In Hyuk Chung, Young June Choe, Jin Yong Kim and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean medical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Remdesivir: treatment of COVID-19 in special populations.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Hyunju LeeDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0003-0107-0724
Sujin ChoiDepartment of Pediatrics, Seoul National University Bundang Hospital, Seongnam, Korea.ORCID https://orcid.org/0000-0001-5476-7029
Ji Young ParkDepartment of Pediatrics, Chung-Ang University Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0002-6777-0494
Dae Sun JoDepartment of Pediatrics, Jeonbuk National University Medical School, Jeonju, Korea.ORCID https://orcid.org/0000-0002-3141-9539
Ui Yoon ChoiDepartment of Pediatrics, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-7190-8812
Heayon LeeDivision of Pulmonary, Critical Care and Sleep Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0001-7389-2343
Yun Tae JungDepartment of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Korea.ORCID https://orcid.org/0000-0002-3583-7105
In Hyuk ChungDepartment of Pediatrics, National Health Insurance Corporation Ilsan Hospital, Goyang, Korea.ORCID https://orcid.org/0000-0002-2694-7679
Young June ChoeDepartment of Pediatrics, Korea University Anam Hospital, Seoul, Korea.ORCID https://orcid.org/0000-0003-2733-0715
Jin Yong KimDivision of Infectious Diseases, Department of Internal Medicine, Incheon Medical Center, Incheon, Korea.ORCID https://orcid.org/0000-0002-4306-1597
Young-Joon ParkKorea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0000-0002-5971-7829
Eun Hwa ChoiDepartment of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. eunchoi@snu.ac.kr.ORCID https://orcid.org/0000-0002-5857-0749
Seoul National University · KRChung-Ang University Hospital · KRIncheon Medical Center · KRJeonbuk National University · KRKorea Disease Control and Prevention Agency · KRKorea University Medical Center · KRNational Health Insurance Service · KRSt. Mary's Hospital · USUlsan College · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCoronavirus disease 2019 (COVID-19) is generally asymptomatic or mild in otherwise healthy children, however, severe cases may occur. In this study, we report the clinical characteristics of children classified as critical COVID-19 in Korea to provide further insights into risk factors and management in children.

methodsThis study was a retrospective case series of children < 18 years of age classified as critical COVID-19. Cases were identified by the Korea Disease Control and Prevention Agency surveillance system and medical records were reviewed. Critical COVID-19 was defined as cases with severe illness requiring noninvasive (high flow nasal cannula, continuous positive airway pressure, or bilevel positive airway pressure) or invasive mechanical ventilation, extracorporeal membrane oxygenation (ECMO) or continuous renal replacement therapy (CRRT), between January 20, 2020 and October 7, 2021.

resultsAmong 39,146 cases diagnosed with COVID-19 in subjects < 18 years of age, eight cases (0.02%) were identified as critical COVID-19. The median age was 13 years (range 10 month-17 years) and male-to-female ratio was 1:1. Three children had underlying diseases; one child has asthma and major depressive disorder, one child had Lennox-Gastaut syndrome and one child had mental retardation and was newly diagnosed with type 2 diabetes mellitus with the diagnosis of COVID-19. Among the eight children, seven were obese (body mass index range [BMI] median 29.3, range 25.9-38.2, weight-for-length > 97% for infant) and one was overweight (BMI 21.3). All patients had fever, six patients had dyspnea or cough and other accompanied symptoms included sore throat, headache, lethargy and myalgia. Radiologic findings showed pneumonia within 1-8 days after symptom onset. Pneumonia progressed in these children for 2-6 days and was improved within 5-32 days after diagnosis. Among the eight critical cases, remdesivir was administered in six cases. Steroids were provided for all cases. Inotropics were administered in one case. Six cases were treated with noninvasive mechanical ventilator and three required mechanical ventilator. One case required ECMO due to acute respiratory distress syndrome. All cases were admitted to the intensive care unit and admission period ranged from 9-39 days. Among all critical COVID-19 cases < 18 years of age, there were no fatal cases.

conclusionTo develop appropriate policies for children in the COVID-19 pandemic, it is important to monitor and assess the clinical burden in this population.

Indexed as

SARS-CoV-2AdolescentChildChild, PreschoolCOVID-19Critical CareFemaleHumansInfantMaleRepublic of KoreaRetrospective StudiesSeverity of Illness IndexChildCOVID-19Critical CareKorea

Identifiers

PMID34981683
PMCPMC8723896
OpenAlexW4205818954

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.